Simona Skerjanec, M.Pharm, MBA
Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Simona Skerjanec, M.Pharm, MBA
Simona Skerjanec, M.Pharm, MBA is recorded as Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed July 24, 2024 that Simona Skerjanec, M.Pharm, MBA was appointed member of the board of directors, effective July 22, 2024.
“On July 24, 2024, Immunic, Inc. (the "Company") announced the appointment of Simona Skerjanec, M.Pharm, MBA, as a member of the board of directors (the "Board") of the Company, effective as of July 22, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.